# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-028263
Filing Date
2021-11-15
Accepted
2021-11-12 21:13:05
Documents
53
Period of Report
2021-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1256793
2 |  | ex31-1.htm | EX-31.1 | 12009
3 |  | ex31-2.htm | EX-31.2 | 11976
4 |  | ex32-1.htm | EX-32.1 | 9976
| Complete submission text file | 0001493152-21-028263.txt |  | 5873381

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | envb-20210930.xsd | EX-101.SCH | 49338
6 | XBRL CALCULATION FILE | envb-20210930_cal.xml | EX-101.CAL | 38807
7 | XBRL DEFINITION FILE | envb-20210930_def.xml | EX-101.DEF | 197755
8 | XBRL LABEL FILE | envb-20210930_lab.xml | EX-101.LAB | 392628
9 | XBRL PRESENTATION FILE | envb-20210930_pre.xml | EX-101.PRE | 293563
10 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1027390

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38286 | Film No.: 211405823
SIC: 2834 Pharmaceutical Preparations